Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04059705 |
Other study ID # |
STUDY00003525 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
April 4, 2023 |
Est. completion date |
September 17, 2023 |
Study information
Verified date |
November 2023 |
Source |
State University of New York at Buffalo |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive
decline of normal aging and severe dementia associated with Alzheimer's disease (AD). In the
United States about 20% of older adults have MCI. Loss of cognitive function in aging can
have far-reaching and devastating impacts on functional status, independence, and quality of
life. Unfortunately, the therapeutic options to slow progression of cognitive decline in
aging are limited. Dual-task training; that which involves simultaneous cognitive and motor
challenges, is a high-impact potential therapy to slow progressive loss of both motor and
cognitive function in aging. The purpose of this trial is to examine the feasibility and
therapeutic impact of a novel dual-task physical activity intervention on executive and motor
functions among adults, 65 years or older, who have MCI. the investigative team anticipates
that findings from this trial will inform development of larger community-based studies
focused on improving function and ability to maintain independence in older age.
Description:
Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive
decline of normal aging and severe dementia associated with Alzheimer's disease (AD). In the
United States about 20% of older adults have MCI, and approximately 15% per year of those
with MCI will progress to AD. With our rapidly aging society, we are approaching a public
health crisis for which we are not fully prepared. Impaired cognitive function in aging can
have far-reaching and devastating impacts on functional status, ability to maintain
independence, and overall quality of life. Unfortunately, the therapeutic options to slow
progression of cognitive decline in aging are limited.
Dual-task training that involves simultaneous cognitive and motor challenges improves certain
domains of both cognitive and motor function in older adults with MCI. However, we do not yet
know the optimal methods of delivering this high-impact potential therapy in community-based
settings with unique limitations and strengths. Therefore, the aims are to; 1) test the
feasibility of conducting a community-based dual-task (thinking while exercising) physical
activity intervention among adults, 65 years or older, with MCI; and 2) examine the impact of
dual-task training on attention and motor function among adults, 65 years or older, with MCI.
To accomplish these aims the investigators will conduct an 12-week, dual-task training
program using the SmartFit Multisensory Fitness System (Oxnard, CA) among older adults with
MCI. Our group-based training program involves two 1-hour training sessions per week,
designed to simultaneously engage the mind and body, while promoting self-efficacy. Attention
and motor function will be assessed prospectively.
The investigators anticipate that findings from this trial will inform development of methods
to bring evidence-based, non-invasive therapies into communities in need, in order to
preserve function, independence, and quality of life well into older age.